Immuno Oncology Market by 2022- A Global Forecast
World’s one of the biggest and liable market research resource, Research and Markets recently published Immuno-Oncology Market, By Type and
Read moreWorld’s one of the biggest and liable market research resource, Research and Markets recently published Immuno-Oncology Market, By Type and
Read moreIndian regulatory authority Central Drugs Standards Control Organization (CDSCO) released an alert on 21st Jan 2015 informing state and local
Read moreBASEL, Switzerland and NUTLEY, NJ: Roche has announced the commencement of its first Phase 1 clinical trial to evaluate the
Read moreThe United States Food and Drug Administration has approved vemurafenib (Zelboraf), a drug designed to treat patients with metastatic melanoma.
Read moreWASHINGTON (AP) — The United States Food and Drug Administration has approved the first and one-of-a-kind drug manufactured by Roche
Read moreTARRYTOWN, N.Y. (AP) — Earlier on Tuesday, Regeneron Pharmaceuticals Inc. announced that FDA review of the company’s experimental eye drug,
Read moreInformation gathered from close sources reveal that the US regulatory agency might approve an oral BRAF inhibitor vemurafenib jointly developed
Read moreFLORENCE, S.C. (AP) — Roche has returned to the state the financial aid offered to keep the company’s Florence plant
Read more